
USANA is owned by USANA Health Sciences Inc., a publicly traded nutritional supplement company headquartered in Salt Lake City, Utah, that trades on the NYSE under ticker USNA. Founded in 1992 by scientist Myron Wentz, the brand is sold through a direct sales model across 24 markets, with Asia Pacific as its largest region. The parent reported 925.3 million dollars in net sales for fiscal 2025.
Parent Company
Founded
1992
Status
Private
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| USANA | USANA Health Sciences Inc. | Wholly owned |
Myron Wentz founded USANA in 1992 in West Valley City, Utah, after building a scientific reputation with his earlier company, Gull Laboratories, which developed viral diagnostic assays. A microbiologist and immunologist, Wentz launched USANA to apply cellular nutrition science to consumer supplements.
The company adopted a direct sales model from the beginning, using independent Associates rather than retail distribution. It went public on the NASDAQ in 1996 before moving to the NYSE, giving it capital access while keeping founder involvement through Wentz's chairmanship.
Growth through the 2000s and 2010s was driven by international expansion, with Asia Pacific becoming the dominant market as direct selling expanded in China and Southeast Asia. Manufacturing was added in China alongside the Utah base to serve that region.
Recent years have been softer. Net sales declined from about 1 billion dollars in 2022 to 925.3 million dollars in fiscal 2025 amid slower distributor activity and currency pressure, prompting product reformulation and digital investment under CEO Jim Brown.
What does USANA Health Sciences own?
USANA sells nutritional supplements, personal care, and wellness products under a single master brand, with product lines including CellSentials, Celavive, and Proglucamune rather than separate brands.
Is USANA Health Sciences publicly traded?
Yes. USANA trades on the New York Stock Exchange under the ticker USNA.
Who founded USANA Health Sciences?
Microbiologist and immunologist Myron Wentz founded the company in 1992 after building his scientific reputation through viral diagnostics at Gull Laboratories. He remains chairman.
Where is USANA Health Sciences headquartered?
The company is headquartered in Salt Lake City, Utah, where it also operates its main manufacturing facility. A second plant operates in China.
How many brands does USANA Health Sciences own?
It operates under the single USANA master brand, with named product lines rather than a multi-brand portfolio.
Who owns USANA Health Sciences?
USANA is publicly owned by shareholders through its NYSE listing. Founder Myron Wentz remains chairman and a significant insider, but control rests with public stockholders.
What is USANA Health Sciences' revenue?
The company reported 925.3 million dollars in net sales for fiscal 2025, with net income of 31.4 million dollars. Asia Pacific is its largest regional market.
USANA runs charitable programs through the USANA Foundation, which funds nutrition for children in need, and reports sustainability initiatives across its manufacturing operations. It does not carry third-party consumer certifications such as B Corp status.
Its ethics are shaped by the direct sales model, which draws scrutiny around distributor earnings. USANA publishes income disclosure statements and leans on product science and manufacturing quality as its defense within a category under persistent regulatory attention.
The brand faces criticism common to multi-level marketers, particularly around the gap between advertised earnings and median Associate income. Income disclosures are published, but the model itself invites regulatory and reputational scrutiny.
USANA has not had major product safety scandals, though like all supplement makers it operates under FDA dietary supplement rules and periodic labeling and claims review. Its NYSE status means risks are disclosed publicly, which is a transparency edge over private direct sellers.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Melaleuca | USA | 1985 | Premium | Global | All Genders | |
| Harbin Pharmaceutical Group | USA | 1935 | Mass market | United states | Unisex | |
| Nestle | United States | 1971 | Mass market | Global | All-ages | |
| Walmart | USA | 1995 | Mass market | United states | All Genders |
Healthcare PharmaceuticalsOwned by Melaleuca Inc.
Wellness and home products brand of privately held Melaleuca Inc., sold through a membership model across 20 countries.
Retail EcommerceOwned by Harbin Pharmaceutical Group Holding Co., Ltd.
Pittsburgh-based vitamins and supplements retailer wholly owned by China's Harbin Pharmaceutical Group since a 2020 bankruptcy sale, operating roughly 1,900 U.S. stores.
Healthcare PharmaceuticalsOwned by Nestlé S.A.
American vitamins and supplements brand owned by Nestle, pending sale to Yellow Wood Partners as part of a $1 billion holistic health carveout.
Healthcare PharmaceuticalsOwned by Walmart Inc.
Walmart's private label brand of vitamins, minerals, and dietary supplements sold exclusively at Walmart stores and online.
Market Positioning: USANA competes with 4 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by USANA Health Sciences Inc., giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Melaleuca Inc.
Wellness and home products brand of privately held Melaleuca Inc., sold through a membership model across 20 countries.
Melaleuca operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Arthrex Inc.
Orthopedic device brand of privately held Arthrex Inc., specializing in arthroscopic surgery products sold in more than 100 countries.
Arthrex operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by GE HealthCare Technologies Inc.
Independent publicly traded healthcare technology company spun off from General Electric in January 2023, providing medical imaging, diagnostics, and healthcare IT solutions globally.
GE HealthCare operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by HCA Healthcare, Inc.
HCA Healthcare is the flagship brand of the largest U.S. for-profit hospital operator, a network of 190 hospitals and about 2,500 ambulatory sites across 19 states and England.
HCA Healthcare operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Ivoclar Vivadent AG
Dental products brand of family-owned Ivoclar Vivadent AG, maker of IPS e.max ceramics and equipment sold in about 130 countries.
Ivoclar operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Pfizer Inc.
American multinational pharmaceutical corporation developing and manufacturing medicines, vaccines, and consumer healthcare products, one of the world's largest pharmaceutical companies.
Pfizer operates independently without a large parent corporation.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Consumer DNA testing brand now run as a nonprofit under TTAM Research Institute following the 2025 bankruptcy sale of 23andMe Holding Co.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Abbott Laboratories' medical device business spanning cardiovascular, diabetes care (FreeStyle Libre), neuromodulation, and structural heart, generating roughly $20 billion annually.